Ovarian Cancer Biomarker Screening: Still Too Early to Tell (Q57055273)

The CA 125 tumour-associated antigen: a review of the literature

21 January 2018

1 reference

Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study

21 January 2018

1 reference

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

21 January 2018

1 reference

Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.

21 January 2018

1 reference

Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers

21 January 2018

1 reference

The roles of multiple proteomic platforms in a pipeline for new diagnostics

21 January 2018

1 reference

Validation of serum biomarkers for detection of early-stage ovarian cancer.

21 January 2018

1 reference

Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.

21 January 2018

1 reference

Effects of blood collection conditions on ovarian cancer serum markers

21 January 2018

1 reference

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

21 January 2018

1 reference

Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass

21 January 2018

1 reference

Systematic evaluation of candidate blood markers for detecting ovarian cancer

21 January 2018

1 reference

Combining multiple biomarker models in logistic regression.

21 January 2018

1 reference

The preclinical natural history of serous ovarian cancer: defining the target for early detection

21 January 2018

1 reference

Combining biomarkers to detect disease with application to prostate cancer

21 January 2018

1 reference

A model free approach to combining biomarkers.

21 January 2018

1 reference

Ovarian cancer diagnosis with complementary learning fuzzy neural network

21 January 2018

1 reference

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.

21 January 2018

1 reference

A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker

21 January 2018

1 reference

A randomized study of screening for ovarian cancer: a multicenter study in Japan

21 January 2018

1 reference

Results from four rounds of ovarian cancer screening in a randomized trial

21 January 2018

1 reference

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

21 January 2018

1 reference